The Non-Oncology Precision Medicine Market is poised to value over USD 125 billion by 2028 end at a CAGR of over 11% during the forecast period 2022 to 2028. The precision medicine approach to patient care is based on the idea that a patient with cancer, an immunodeficiency disorder, or a genetic disorder may not […]
